From groundbreaking findings from the UK Medical Cannabis Registry to clinical trials by the industry’s leading experts, explore the latest advancements in medical cannabis research.
Chronic pain – defined as pain that persists for more than three months – represents a significant challenge ...
Pain is the most reported symptom among the general population. It can be associated with a wide range ...
What is insomnia? Insomnia is a sleep disorder that is characterised by being unable to get to sleep ...
Cannabis is among the most used drugs in the world, with consumers using various forms for both recreational ...
Cannabis has long been one of the most commonly used drugs in the world, with people using various ...
Chronic pain is recognised to activate several brain areas, which underlies affective aspects of the pain experience. For ...
Diabetic distal symmetric polyneuropathy (DSP) is the presence of symptoms and signs of nerve damage/dysfunction that may occur ...
Chronic non-cancer pain is estimated to affect around 20% of the global population and is associated with reduced ...
Anxiety, a common mental health condition, is on the rise in many parts of the world. It is ...
In recent years, cannabis use has been on the rise among patients with a wide range of conditions. ...
What are clinical trials? Clinical trials are research studies that test a medical, surgical, or behavioural intervention in ...
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders. It is usually first diagnosed in childhood; ...
